CD8A and neoplasm: In melanoma-bearing mice, DOX in drug-loaded nanoparticles significantly increased matured DCs, CD8+ T cells, IFN-γ, and TNF-α, while reducing Treg cells and downregulating PD-L1 expression; this resulted in the improvement of the TME, suppression of tumor, and prolongation of the survival rate.